G-CON Manufacturing and GE Healthcare Announce Intent to Collaborate in Developing Next Generation Modular Bio-therapeutic Manufacturing Technology
News Dec 03, 2010
This collaboration combines GE Healthcare’s global presence and expertise in biopharmaceutical manufacturing technology with G-Con’s modular portable flexible clean-room technology. The collaboration will offer comprehensive GMP manufacturing solutions that are less expensive and quicker to build and maintain and easier to operate than any currently existing solution on the market.
Together, the companies have the capability to design, build and deliver turnkey advanced bio-therapeutic manufacturing facilities throughout the world, and will be able to meet the growing market for rapid access to biopharmaceutical manufacturing capabilities, whether in developing markets, or for increased speed in situations such as pandemic response.
“GE Healthcare is a global life sciences leader, and we are excited by the market-changing next generation therapeutic manufacturing innovations this collaboration will be able to produce,” said Dr. Barry Holtz, President of G-Con Manufacturing, LLC.
“This collaboration is part of GE Healthcare’s mission to increase speed and access, and reduce cost for developers and manufacturers of bio-therapeutics and vaccines around the world,” said Nigel Darby, Vice President, Biotechnologies, GE Healthcare. “This collaboration means we move further towards our vision of modular and possibly mobile flexible bio-pharmaceutical manufacturing facilities – the vaccine factory in a box.”
Researchers have developed an artificial enzymatic pathway for synthesizing isoprenoids, or terpenes, in E. coli. This shorter, more efficient, cost-effective and customizable pathway transforms E. coli into a factory that can produce terpenes for use in everything from cancer drugs to biofuels.READ MORE
2nd International Conference on Pharmaceutical Research & Innovations in Pharma Industry
May 30 - May 31, 2019